Drawing for ENDPOINT RESEARCH LTD.

USPTO serial 78094940

ENDPOINT RESEARCH LTD.

Reviewed by CopyMark Law Group

Reg. 2693394Status 710
Filing date
Status date
Registration date
Mar 4, 2003
Examiner
MEIER, SHARON A
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ENDPOINT RESEARCH LTD.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gordon E. R. Troy

GORDON E R TROY GORDON E R TROY, PCP O BOX 368; 3333 LAKE RDCHARLOTTE, VT 05445UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business services, namely providing computer databases regarding clinical trials for others by means of a global computer network; packaging services for the pharmaceutical industry, namely, packaging pharmaceuticals to the order and specification of others for use in clinical trials; computerized database management and data processing services in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices; customized analysis of health care, pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices data for others; business marketing research, business auditing and business consulting services in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices provided by non-electronic means or by means of wide area networks or a global computer network; and distribution, tracking and management of clinical trial supplies and research materials used in such trials; and providing statistical information and analysis via computer for use with clinical trial dataSECTION 8 - CANCELLEDAug 1, 1996
042Medical and scientific research, namely conducting clinical trials; collecting and providing information regarding clinical trials by means of a global computer network for purposes of improving clinical trial management; providing pharmaceutical outsourcing services in the field of clinical trials by means of a global computer network, namely, organizing and reporting data from clinical trials for pharmaceuticals and medical devices; bioanalytical immunoanalytical, and protein chemistry analytical services provided to pharmaceutical companies in connection with clinical studies of pharmaceuticals; providing contract research and development services in the field of pharmaceuticals and medical devices Computer services, namely, providing an on-line database in the field of pharmaceuticals; computer services, namely, providing on-line conferencing services in the field of pharmaceuticals; computer services, namely, providing on-line information, news and reports of new developments in the field of pharmaceuticals; providing information on non-clinical studies of pharmaceuticals and medical devices via the Internet; providing information in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices by means of wide area networks or a global computer network; consulting services in the fields of health care, pharmaceuticals, veterinary, pharmacogenomic, biotechnical, and medical products and devices provided by non- electronic means or by means of wide area networks or a global computer network; clinical research services, namely, conducting programs to assist patients in pharmaceutical and medical device clinical trails in their transition from experimental to mass-approved products and treatments; Medical and scientific research, namely providing clinical trial analysis and studies, and data preparation for use by insurance companies and third party medical reimbursement organizations to determine treatment coverage; providing clinical trial data information via the world wide webSECTION 8 - CANCELLEDAug 1, 1996

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2009C8..CANCELLED SEC. 8 (6-YR)—
Mar 3, 2008CFITCASE FILE IN TICRS—
Mar 4, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 10, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2002NPUBNOTICE OF PUBLICATION—
Sep 14, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance